Forbes @Forbes
The FDA reportedly turned down a bid from Neuralink, the ambitious yet controversial human brain chip startup founded by the nation’s richest man Elon Musk, to begin human trials, a major setback for the ambitious yet controversial startup. https://t.co/9a3OehI46d — PolitiTweet.org